AlphaFold predicted structure
DOLK · Q9UPQ8

Mean pLDDT
90.1/ 100
Very high
538 residues
Confidence breakdown
- Very high(≥ 90)73%
- Confident(70–90)21%
- Low(50–70)3%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dolichol kinase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalCongenital muscular dystrophy
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalDilated and arrhythmogenic cardiomyopathy
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomal+5 more panels — install the extension to see the full list inline on any page.
DK1-congenital disorder of glycosylation
Abnormality of the cardiovascular system
congenital disorder of glycosylation
familial isolated dilated cardiomyopathy
SRD5A3-congenital disorder of glycosylation
congenital disorder of glycosylation type I
dilated cardiomyopathy
hypertrophic cardiomyopathy 26
male reproductive organ cancer
hyperinsulinemic hypoglycemia, familial, 4
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Dolichol kinase
Catalyzes CTP-mediated phosphorylation of dolichol, the terminal step in de novo dolichyl monophosphate (Dol-P) biosynthesis (PubMed:12213788, PubMed:16923818, PubMed:17273964, PubMed:22242004). Dol-P is a lipid carrier essential for the synthesis of N-linked and O-linked oligosaccharides and for GPI anchors (PubMed:12213788)
DOLK · Q9UPQ8

Mean pLDDT
90.1/ 100
Very high
538 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0